Amrutanjan Health Care Ltd.

•

amrutanjan.comBSE: 590006NSE: AMRUTANJAN

Market Cap₹ 1,418 Cr.

Current Price

High / Low₹ 774 / 483

Stock P/E67.0

Book Value—

Price to Book—

Dividend Yield1.00 %

ROCE31.7 %

ROE20.2 %

Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2016 • OTC Products: 86.4% • Beverages: 11.6% • Chemicals: 1.3%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 26.3%
Company has consistently been profitable over the last 5 years
Operating margins have improved to 18.6% from 14.9%
Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.18x)

CONS

Promoter holding has decreased over last 2 years: -4.1pp
Expensive relative to growth - PEG of 2.5

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1842.00	36.54	441957.50	0.87	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9326.00	84.64	247576.00	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4975.00	86.76	189233.01	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1119.50	24.74	111670.55	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1365.00	32.72	110272.68	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1970.35	97.37	106460.42	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	DRREDDY	1161.00	30.07	96906.38	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
8.	AUROPHARMA	1675.45	25.97	96401.69	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
9.	LUPIN	2096.00	17.34	95842.92	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
10.	MANKIND	2277.00	46.04	94050.37	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2416.90	37.94	68210.88	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AMRUTANJAN	490.35	67.05	1417.63	1.00	4.37	-47.46	102.97	9.48	22.46	6.06

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

No quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016
	105	143	138	142	167	187
	92	125	120	121	143	156
Operating Profit	13	18	17	21	24	31
OPM %	12.50%	12.73%	12.65%	14.75%	14.15%	16.49%
	5	4	4	4	4	6
Interest	1	3	2	2	1	0
Depreciation	2	4	4	4	3	3
Profit before Tax	15	16	15	19	24	33
Tax %	33.61%	38.98%	34.62%	35.79%	38.28%	37.05%
Net Profit	10	10	10	12	15	21
EPS	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Payout %	44.51%	45.51%	43.34%	37.58%	34.32%	27.35%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 12%
3 Years:: 11%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 15%
3 Years:: 27%

STOCK PRICE CAGR

10 Years:: 9%
5 Years:: -7%
3 Years:: -8%
1 Year:: -35%

RETURN ON EQUITY

10 Years:: —
5 Years:: 15%
3 Years:: 17%
Last Year:: 20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016
Equity Capital	3	3	3	3	3	3
	98	74	79	86	92	106
	30	21	16	8	3	3
Trade Payables	7	10	9	7	8	9
	18	16	18	16	18	20
Total Liabilities	157	124	124	120	124	140
	52	33	30	27	24	29
Capital Work in Progress	0	0	1	1	4	1
	42	29	25	9	9	9
	10	13	10	9	9	9
	0	0	0	0	0	0
Cash & Bank	24	15	15	35	38	48
	27	34	44	39	40	45
Total Assets	157	124	124	120	124	140

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016
	10	9	14	25	28	32
Cash from Investing	-29	14	8	16	-5	4
Cash from Financing	20	-27	-14	-14	-12	-13
	-4	-9	2	20	1	12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.59	46.52	46.52	46.52	46.52	46.52	46.52	46.52	46.52
	1.55	2.34	2.30	2.30	2.41	2.38	2.27	2.17	2.44
	7.32	10.60	11.13	11.41	12.70	12.90	13.00	12.66	12.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	40.54	40.54	40.06	39.77	38.37	38.20	38.22	38.65	38.76

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28

Updates

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding 'BRSR for the FY 2025-26'.

2026-08-28

Shareholders meeting

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-12

Investor Presentation

2026-08-12 - Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation

2026-08-11

Record Date

2026-08-11 - Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-08-11

Outcome of Board Meeting

2026-08-11 - Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-05

Commencement of commercial production/operations

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Commencement of commercial production/operations

2026-08-05

Credit Rating

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Credit Rating

2026-08-01

Action(s) taken or orders passed

2026-08-01 - Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed

2026-07-08

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-08 - Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for AMRUTANJAN

Loading news…

🤖

AI Stock Analyst

Amrutanjan Health Care Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1842.00

36.54

441957.50

0.87

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9326.00

84.64

247576.00

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4975.00

86.76

189233.01

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1119.50

24.74

111670.55

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1365.00

32.72

110272.68

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1970.35

97.37

106460.42

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

DRREDDY

1161.00

30.07

96906.38

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1675.45

25.97

96401.69

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2096.00

17.34

95842.92

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2277.00

46.04

94050.37

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2416.90

37.94

68210.88

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

AMRUTANJAN

490.35

67.05

1417.63

1.00

4.37

-47.46

102.97

9.48

22.46

6.06

Mar 2011

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

105

143

138

142

167

187

125

120

121

143

156

Operating Profit

OPM %

12.50%

12.73%

12.65%

14.75%

14.15%

16.49%

Interest

Depreciation

Profit before Tax

Tax %

33.61%

38.98%

34.62%

35.79%

38.28%

37.05%

Net Profit

EPS

0.00

Dividend Payout %

44.51%

45.51%

43.34%

37.58%

34.32%

27.35%

Mar 2011

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Equity Capital

106

Trade Payables

Total Liabilities

157

124

120

124

140

Capital Work in Progress

Cash & Bank

Total Assets

157

124

120

124

140

Mar 2011

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Cash from Investing

-29

-5

Cash from Financing

-27

-14

-12

-13

-4

-9

Mar 2011

Mar 2012

Mar 2013

Mar 2014

Mar 2015

Mar 2016

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

50.59

46.52

1.55

2.34

2.30

2.41

2.38

2.27

2.17

2.44

7.32

10.60

11.13

11.41

12.70

12.90

13.00

12.66

12.29

Government

0.00

40.54

40.06

39.77

38.37

38.20

38.22

38.65

38.76

Amrutanjan Health Care Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Amrutanjan Health Care Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI